Novartis Stock: Sandoz Family Reduces Significant Stake
The investment company of the Sandoz family, Emasan AG, has divested a substantial portion of its holdings in Swiss pharmaceutical giant Novartis. Through an accelerated bookbuilding process, 26.5 ...
Sandoz Family to Sell $2.9 Billion Stake in Novartis
(Bloomberg) -- Novartis AG’s Sandoz family is poised to sell a roughly 1.2% stake in the Swiss pharmaceutical group.
Sandoz family to get $2.9 billion from offloading part of its Novartis stake
The investment vehicle of the Sandoz family will get 2.6 billion Swiss francs ($2.90 billion) from selling a chunk of Swiss ...
Sandoz family foundation offers $3 billion worth of Novartis shares
Emasan AG, an arm of the Sandoz Family Foundation, has launched a public offering of some 26.5 million shares in Swiss ...
Novartis holder Emasan selling 26.5M shares, Bloomberg reports
Emasan AG is offering around 26.5M shares in Swiss Novartis (NVS) through Goldman Sachs, potentially raising $3B, Pablo Mayo Cerqueiro of ...
Sandoz Family Pares Novartis Stake With $2.9 Billion Sale
Novartis AG’s Sandoz family sold a roughly 1.2% stake in the Swiss pharmaceutical group for 2.6 billion Swiss francs ($2.9 ...
Emasan files to sell 26.5M shares of Novartis, Bloomberg reports
11:49 EST Emasan files to sell 26.5M shares of Novartis ( NVS ), Bloomberg reports Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> ...
Events Calendar for:
Find earnings, economic, stock splits and IPO calendars to track upcoming financial events from Yahoo Finance.